Place Raymond Blyckaerts, 13
B-1050 Brussels, Belgium

Opening hours:
Mon to Thu: 10h - 12h30 and 13h30 - 17h
Fri: 10h - 12h30 and 13h30 - 16h

Google maps

Find us on
Google Maps
To subscribe to our newsletter, please click here. If you would like to become an EATG member, please fill in the form here. You can also subscribe to our RSS feed by clicking here.
You can also follow us on one of these media :

AIDS 2014 closes in Melbourne

No one can be left behind if the AIDS epidemic is to come to an end by 2030. This was one of the main messages of the 20th International AIDS Conference, which closed in Melbourne, Australia, on 25 July. Remembering the tragic events of the flight MH17 disaster, at the closing ceremony tributes were paid to the delegates tragically killed on their way to the conference. AIDS...


Source Source: UNAIDS

Raltegravir not better than NRTIs for refractory HIV

Raltegravir offers no benefits over nucleoside reverse-transcriptase inhibitors (NRTIs) when used in combination with a protease inhibitor (PI) as second-line HIV therapy, according to an open-label, randomized study published in the July 17 issue of the New England Journal of Medicine . Ritonavir-boosted PI (lopinavir) plus 2 NRTIs was similarly effective to a PI...


Source Source: Medscape

Tags: Treatment

Maximizing the benefits of antiretroviral therapy for key populations

A White Paper by the Key Affected Populations and Treatment as Prevention Working Groups of the International AIDS Society

Read the document here.

HIV/AIDS: Top Russian scientist accuses research community of snub

Russian scientists have accused the international Aids research community of harming people affected by HIV in the region with a “destructive” attempt to isolate Russia. In accusations which have been strongly rebuffed by the International Aids Society, a senior member of the Russian Science Academy complained that a meeting on the state of the HIV epidemic in Eastern...


Source Source: The Indepenedent

Statement of the UNODC Executive Director, Yury Fedotov, on World Hepatitis Day

Vienna, 25 July 2014 - Hepatitis C is a gravely debilitating disease and the growing cause of early death and severe liver disease among those who inject drugs. Of the 12.7 million people estimated to have injected drugs globally, around 50 per cent are believed to have contracted this virus. Many of these individuals have no access to testing, treatment or counselling services and are...


Source Source: UNODC